Atara Biotherapeutics Inc. (ATRA) Atara Biotherapeutics' T-cell immunotherapy ... The current recommended dosage of Leqembi is 10 mg/kg administered intravenously once every two weeks to eligible ...

Check the time stamp on this data. Updated AI-Generated Signals for Atara Biotherapeutics Inc. (ATRA) available here: ATRA.

Atara Biotherapeutics (NASDAQ:ATRA) has announced plans to cut around 50% of its workforce, just a little over a week after it said the FDA had declined to approve its immunotherapy Ebvallo.

Shares of Atara Biotherapeutics (NASDAQ:ATRA) continued to trade lower in the premarket on Tuesday after the U.S. Food and Drug Administration (FDA) slapped the cell therapy developer with a ...

Shares of Atara Biotherapeutics ATRA plunged 40.5% on Thursday after the FDA issued a complete response letter (CRL) against ...

Price Action: ATRA stock is down 4.09% at $6.302 at last check Tuesday.

NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Airbus announced that, on Jan. 21, 2025, the A320 ATRA (Advanced Technology Research Aircraft) flew for the first time from the German Aerospace Center (DLR) in Braunschweig, Germany, after the ...

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...